Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Clinical trial NCT04514484 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04514484
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Differentiated Thyroid Gland Carcinoma Advanced Head and Neck Carcinoma Advanced Hepatocellular Carcinoma Advanced Kaposi Sarcoma Advanced Lung Non-Small Cell Carcinoma Advanced Lung Small Cell Carcinoma Advanced Malignant Solid Neoplasm Advanced Melanoma Advanced Ovarian Carcinoma Advanced Prostate Carcinoma Advanced Renal Cell Carcinoma Advanced Thyroid Gland Medullary Carcinoma

Start date: 2021-11-22
Primary completion: 2024-11-11
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.